-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Tandem Diabetes Care, Raises Price Target to $20

Benzinga·11/06/2026 16:37:03
Listen to the news
Barclays analyst Christopher Pasquale maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price target from $18 to $20.